Koller launched insitro last year with over $100 million in Series A financing raised by investors that embody some huge names—including Jeff Bezos’ enterprise capital firm Bezos Expeditions, GV , and Google father or mother Alphabet’s life science analysis group Verily. “We are excited to work with Gilead, a leader in liver illness, in bringing to bear novel instruments toward identifying new therapeutics for NASH and serving to the numerous patients in want around the world,”…